Compare CIA & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIA | LAB |
|---|---|---|
| Founded | 1969 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.3M | 326.2M |
| IPO Year | 1995 | 2008 |
| Metric | CIA | LAB |
|---|---|---|
| Price | $3.77 | $0.67 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 149.6K | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $255,616,000.00 | $101,937,000.00 |
| Revenue This Year | $3.10 | N/A |
| Revenue Next Year | $4.47 | $2.63 |
| P/E Ratio | $28.23 | ★ $2.49 |
| Revenue Growth | ★ 4.33 | N/A |
| 52 Week Low | $3.56 | $0.63 |
| 52 Week High | $6.54 | $1.72 |
| Indicator | CIA | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 28.15 | 38.50 |
| Support Level | $3.56 | N/A |
| Resistance Level | $5.63 | $0.99 |
| Average True Range (ATR) | 0.24 | 0.05 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 20.17 | 22.82 |
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Domestic Insurance and International Insurance segments.. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.